© 2020 Arizent. All rights reserved.

Invesco replants flag in European CLO market

Register now

Invesco Senior Secured Management is issuing its first European CLO since the financial crisis, according to Moody’s Investors Service.

Invesco Euro CLO 1 DAC (Designated Activity Co.) is among the deals closing out the 2018 European CLO market in pricing a €409.8 million portfolio of non-investment grade broadly syndicated loans, according to Moody's. The portfolio represents the first European collateralized loan obligation deal by the Atlanta-based global asset manager since 2006.

The deal, placed through Barclays, will be managed by the Invesco European RR L.P. subsidiary of Invesco. It also put the wraps on a record year of post-crisis European CLO issuance at €27.3 billion, besting 2017's €20.5 billion volume, according to a new CLO monthly report issued by Wells Fargo (citing data from Wells, Intex, S&P Global Ratings and Moody's Investors Service).

The transaction has a five-year reinvestment period and is non-callable for two years. Two senior tranche of notes will be issued: €214.4 million of Class A-1 notes priced at 102 basis points above the three-month/six-month Euribor rate, and €30 million in Class A-2 notes that pay a fixed coupon of 1.44%.

Invesco had €318.5 million of the portfolio of loans assigned to the portfolio at the time of the cutoff date, with a weighted average spread of 3.81% and a WA coupon of the underlying loans at 6.75%. The initial weighted average life of the collateral is 5.99 years, although the deal's covenant allow for a weighted average life of up to 8.5 years.

The deal has a maximum allowance of 10% of the pool for second-lien loans, senior unsecured obligations and high-yield bonds; up to 30% of the loans can have covenant-lite structures with limited maintenance oversight.

In the identified portfolio, the balance of loans is weighted toward the lower-rated single B variety, with 65.2% of the collateral pool consisting of loans rated B2 or B3 (three and four notches down, respectively, from the highest Moody’s double-B equivalent rating of Ba2).

Nearly 16% of the identified portfolio are loans within the health care and pharmaceuticals industries.

As of Sept. 30, Invesco had €5.7 billion in European loans under management (U.S. loan assets were $41.4 billion). Invesco manages 10 U.S. CLOs totaling $5.2 billion, ranking 40th among U.S. managers, according to Creditflux.

For reprint and licensing requests for this article, click here.
CLOs CDOs Europe